Agencies Experience, Boutique Approach
Want to accelerate your drug development process?
Welcome to Voisin Consulting Life Sciences
VCLS supports life science companies throughout product development, and engages in communication with regulators and payers. We partner with Biotech, Pharma and Medtech manufacturers to develop, register and launch innovative products in North American and European markets.
Through a network of partners, we also assist clients in Southeast Asia, Latin America, and a number of additional markets. We provide people-powered solutions to complement our clients’ in-house resources, from product development strategy, communication with regulators and payers up to market authorization and reimbursement.
How can VCLS help you?
REGULATORY STRATEGY
INTERACTION WITH AUTHORITIES
CLINICAL RESEARCH
SAFETY & PHARMACOVIGILANCE
Regulatory & Health Economics Expert Resources
All news & events
Latest News & Events
-
VCLS, Voisin Consulting Life Sciences announces strategic alliance with Worms Safety
Voisin Consulting Life Sciences (VCLS) and Worms Safety have announced that they have formed a strategic alliance. Through this... -
Biomed 2018
This year we will explore and aim to fuel the innovations and trends that are shaping the future of healthcare systems and life... -
Vitafoods Europe 2018
Vitafoods Europe is a premium event within the nutraceutical industry where key players come together to share knowledge,...
All resources
Latest Resources
-
Market Access for ATMPs Begins at the Bench
Despite their significant therapeutic potential, ATMPs face specific market access challenges compared to other therapeutic... -
Update on The Redistribution of UK’s portfolio of centrally authorised products
In preparation for Brexit, the 27 EU Member States, together with the European Medicines Agency (EMA), have reached a major... -
EU Downplays likelihood of UK staying in EMA after Brexit
In draft guidelines prepared by the President of the European Council, and published on 7 March 2018, the European Council has...